Biohaven Therapeutics Ltd.
USPTO PatentsView assignee record - 27 granted patents across 7 technology areas, recorded in grant years 2019–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations).
The verdict
According to USPTO PatentsView, Biohaven ranks #11,182 of 49,997 tracked US assignees by granted-patent volume, with 27 patents across 7 technology areas.
- #11,182
- of 49,997 US assignees by volume
- Top 29%
- by Innovation Score (43.0/100)
- 10.2
- avg claims per patent
- +1500%
- grant velocity, last 5 yrs
USPTO PatentsView assignee plate
Corpus R11182 · Foreign Corporation #11,182 · 27 grants
GRANTS-SMALL · UPPER-Q · PHOTO-FINISH · CPC-NARROW · INNOV-PAR · CLAIMS-PAR · TYPE-FRNCORP · VEL-SURGE · BOOK-FULL
- GRANTS-SMALL 27 grants
- UPPER-Q #11,182/49,997
- PHOTO-FINISH Bausch + Lomb Ireland
- CPC-NARROW A61P · 7 areas
- INNOV-PAR 43.0/100
- CLAIMS-PAR 10.2 claims/avg
- TYPE-FRNCORP Foreign Corp
- VEL-SURGE +1500% vel
- BOOK-FULL 10/10 fields
Nearest grant-volume peer: Bausch + Lomb Ireland Limited (±0 grants)
Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.
How Biohaven’s 43.0 Innovation Score adds up
The same four weighted components behind every Innovation Score on PlainPatent: portfolio volume, grant velocity, technology breadth, and claim depth.
Innovation-score neighbourhood around Biohaven
Lowest and highest poles plus nearest Innovation Score peers, not a full corpus board reprint.
- Qualcomm Incorporated · highest
Qualcomm Incorporated · highest
85 score
- Accelink · near
Accelink · near
43 score
- Atlantic Inertial… · near
Atlantic Inertial… · near
43 score
- Biohaven Therapeutics · this assignee
Biohaven Therapeutics · this assignee
43 score
- Cyberswitching Patents · near
Cyberswitching Patents · near
43 score
- IPCom & KG · near
IPCom & KG · near
43 score
- 3D Lighting… · lowest 7
3D Lighting… · lowest
7 score
What this shows Biohaven's Innovation Score is 43.0/100 (top 29% of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.
Does more volume mean deeper claims for Biohaven?
Each dot is one of Biohaven’s 8 nearest volume peers (same corpus rank neighbourhood as the chart above), placed by total granted patents (horizontal) against average claims per patent (vertical). Biohaven’s own 10.2 claims/patent is at or below the 18.7 median for these volume peers. Volume here does not track with deeper claims; several lower-volume peers claim more thoroughly per patent.
Where Biohaven's grants concentrate
Biohaven Therapeutics Ltd. is a focused PatentsView assignee: 7 CPC subclasses with 96.3% of grants classified under A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations). Peak complete grant year is 2024 (7 grants) versus a trough of 1 in 2019. By volume, Biohaven sits between Bwxt Nuclear Energy, Inc. and Brandywine Product Group International Inc..
Biohaven's three-year grant acceleration
Biohaven Therapeutics Ltd. shows 12 grants in 2022–2024 against only 5 in 2019–2021. That prior window is too thin for a growth multiple (rename and spin-out assignees look artificially high when the baseline is near zero), so PlainPatent withholds a ranked acceleration claim here.
Who files at Biohaven's volume?
Granted US patents 2015–2025 versus its nearest-ranked assignees by volume, this company marked ◀
- Bwxt Nuclear Ener…
Bwxt Nuclear Energy, Inc.
27 patents
- Bausch + Lomb Ire…
Bausch + Lomb Ireland Limited
27 patents
- Belanger
Belanger, Inc.
27 patents
- Bicycletx
BicycleTx Limited
27 patents
- Black Diamond Oil…
Black Diamond Oilfield Rentals LLC
27 patents
- Bloomreach
BloomReach Inc.
27 patents
- Blue Jeans Network
Blue Jeans Network, Inc.
27 patents
- Brandywine Produc…
Brandywine Product Group International Inc.
27 patents
- Biohaven Therapeu… ◀
Biohaven Therapeutics Ltd.
27 patents
What this shows Biohaven holds 27 patents at rank #11,189, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.
Companies ranked near Biohaven
By rank, the assignees closest to #11,189 in granted patent volume.
- Bwxt Nuclear Energy, Inc. #11,185 · 27 patents
- Bausch + Lomb Ireland Limited #11,186 · 27 patents
- Belanger, Inc. #11,187 · 27 patents
- BicycleTx Limited #11,188 · 27 patents
- Black Diamond Oilfield Rentals LLC #11,190 · 27 patents
- BloomReach Inc. #11,191 · 27 patents
- Blue Jeans Network, Inc. #11,192 · 27 patents
- Brandywine Product Group International Inc. #11,193 · 27 patents
Leaders in A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…)
Other assignees with the most granted patents in Biohaven's primary technology class.
- The Regents of the University of California 1,387 in class
- Novartis AG 1,071 in class
- Merck Sharp & Dohme LLC 889 in class
- Bristol-Myers Squibb Company 879 in class
- Genentech, Inc. 789 in class
- The Board of Regents of the University of Texas System 744 in class
- Hoffmann-La Roche Inc. 722 in class
- The United States of America, as represented by the Secretary, Department of Health and Human Services 721 in class
Assignees with similar portfolio profiles
Two PlainPatent-derived peer sets for Biohaven, neither rank-band nor same-CPC leaders (those blocks stay above). In A61P (Specific Therapeutic Activity OF Chemical Compounds OR Me…), Biohaven ranks #760 of 6,058 assignees by patent count in that subclass.
Similar innovation score
Nearest assignees by Innovation Score (43 here).
Biohaven's Innovation Score vs. every tracked assignee
Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)
43 Top 29% higher than 71% of 49,997 US assignees
Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.
Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025
Grants by year
Teal-shaded recent years (2020–present) versus the 2019–2019 baseline. Full figures in the table below.
View data table
| Year | Patents Granted | Share of Period |
|---|---|---|
| 2019 | 1 | 3.7% |
| 2020 | 1 | 3.7% |
| 2021 | 3 | 11.1% |
| 2022 | 1 | 3.7% |
| 2023 | 4 | 14.8% |
| 2024 | 7 | 25.9% |
| 2025partial year | 10 | 37.0% |
Which technologies does Biohaven Therapeutics Ltd. patent most?
Top 7 of 7 technology areas
Data Source
USPTO PatentsView, US granted patents 2015–2025
What to do with this data
Biohaven Therapeutics Ltd.'s patent record in context - here's where to go next.
- Biohaven Therapeutics Ltd.'s lead technology class is A61P (Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations), 96.3% of its portfolio - see every assignee active in that class. Explore A61P
- Ranked #11,182 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
- Compare Biohaven Therapeutics Ltd. against Bwxt Nuclear Energy, Inc., an assignee filing at a similar volume. Compare portfolios
- Innovation Score of 43.0/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated
Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.
Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.